FDA: New Suppliers To Ease Cancer Drug Shortages
Save Email Print
Bookmark and Share
FDA: New Suppliers To Ease Cancer Drug Shortages
Federal regulators say they've approved new suppliers for two crucial cancer drugs, easing critical shortages — at least for the time being — that have patients worried about missing life-saving treatments.
Reporter: Associated Press
width:320 and height: 240 and picwidth: 213 and pciheight: 159
Font Size:

Tuesday, February 21, 2012

Federal regulators say they've approved new suppliers for two crucial cancer drugs, easing critical shortages — at least for the time being — that have patients worried about missing life-saving treatments.

The Food and Drug Administration will temporarily allow importation of a replacement drug for Doxil, a drug for ovarian and other cancers that hasn't been available for new patients for months.

The agency also has approved another supplier for a preservative-free version of methotrexate, a crucial drug for children with a type of leukemia and for high-dose treatment of bone cancer.

The FDA increasingly has been able to prevent drug shortages by getting advance notice from manufacturers, but about 280 drugs currently are in short supply.


Dr. Oz BMI Calculator